Author

Francesca Gorini

University of Naples Federico IIPrimary ORCID profile (0000-0002-9762-4172 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Francesca GoriniiD1 paper · Istituto Nazionale Genetica Molecolare

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Achille IolasconiD· 1 shared Angelo Sabato BocciaiD· 1 shared Biancamaria PierriiD· 1 shared Carmen Sorice· 1 shared Dong-Rac choi· 1 shared Fathem Asadzadeh· 1 shared Francesca BibbòiD· 1 shared Giovanna FuscoiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Achille IolasconORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting ATP2B1 impairs PI3K/Akt/Fox-O3 signaling and reduces SARS-COV-2 replication in vivo.

Pasqualino De Antonellis, Veronica Ferrucci, Francesca Bibbò, Fathem Asadzadeh, Francesca Gorini, Angelo Sabato Boccia, Carmen Sorice, Roberto Siciliano, Roberta Russo, Immacolata Andolfo, Vito Alessandro Lasorsa, Sueva Cantalupo, Giovanni Paolella, Giovanna Fusco, Maurizio Viscardi, , Massimo Zollo

This study shows that inhibiting ATP2B1 with compound PI-7 reduces SARS-CoV-2 replication by lowering intracellular calcium levels and disrupting the PI3K/Akt/FoxO3 signaling pathway.

medRxiv · Sep 2, 2022 · PreprintGenetic & Genomic Medicine